Innovent Biologics Forecast, price target & analysts
Innovent Biologics Target price 2026 - Analyst rating & recommendation
Innovent Biologics Classifications & Recommendation
Innovent Biologics Price Target
| Target Price | HK$131.58 |
| Price | HK$89.05 |
| Potential | |
| Number of Estimates | 29 |
| 29 Analysts have issued a price target Innovent Biologics 2027 . The average Innovent Biologics target price is HK$131.58. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 38 analysts: 35 Analysts recommend Innovent Biologics to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Innovent Biologics stock has an average upside potential 2027 of . Most analysts recommend the Innovent Biologics stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
35 Analysts have issued a sales forecast Innovent Biologics 2026 . The average Innovent Biologics sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
34 Innovent Biologics Analysts have issued a net profit forecast 2026. The average Innovent Biologics net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
34 Analysts have issued a Innovent Biologics forecast for earnings per share. The average Innovent Biologics EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Innovent Biologics...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
